US FDA OKs use of Quest Diagnostics H1N1 flu test
WASHINGTON, July 24 |
WASHINGTON, July 24 (Reuters) - U.S. regulators said Friday they authorized emergency use of a Quest Diagnostics Inc (DGX.N) test for the H1N1 swine flu virus.
The test is the third one authorized by the Food and Drug Administration for diagnosing an infection with the pandemic H1N1 virus, the agency said. It is made by Quest unit Focus Diagnostics. (Reporting by Lisa Richwine, editing by Gerald E. McCormick)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters